Fixed Dose Rate Gemcitabine and Cisplatin Followed by Chemoradiation for Locally Advanced Pancreatic Cancer
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
This is a phase Ⅱ trial of fixed dose rate gemcitabine and cisplatin chemotherapy followed by
chemoradiation with capecitabine in patients with locally advanced pancreatic cancer.